Related Experiment Videos
[Could the BCG vaccine prevent bladder cancer?]
E A Granados Loarca1, V L Ambrosio
1Servicio de Urología, Torre profesional, Quetzaltenango, Guatemala.
Actas Urologicas Espanolas
|July 22, 2004
Summary
Bacille Calmette-Guérin (BCG) vaccination appears to prevent bladder cancer. Patients treated for tuberculosis or vaccinated with BCG for tuberculosis did not develop bladder cancer in this study.
Area of Science:
- Oncology
- Infectious Diseases
- Immunology
Context:
- Tuberculosis (TB) is prevalent in developed nations, while bladder cancer incidence is lower.
- Bacille Calmette-Guérin (BCG) is utilized for tuberculosis prevention and treatment, and also in managing bladder cancer recurrence.
Purpose:
- To investigate the potential relationship between tuberculosis, BCG vaccination, and the development of bladder cancer.
Summary:
- A 14-year retrospective and prospective study analyzed 52 bladder cancer cases and interviewed 100 individuals and medical professionals.
- No bladder cancer patients had received BCG vaccination. Conversely, individuals vaccinated with BCG for tuberculosis prevention did not develop bladder cancer over a mean of 32 years.
- Patients treated for tuberculosis also showed no incidence of bladder cancer, and no cases of co-occurrence or BCG-vaccinated individuals developing bladder cancer were observed.
Impact:
- Findings suggest a potential protective effect of BCG vaccination against bladder cancer development.
- This research could inform public health strategies and cancer prevention initiatives.